One of our previous studies found for the first time that TSLPR expression on platelets was markedly increased in patients with acute coronary syndrome (ACS), which promoted the activation of platelets through phosphatidylinositol 3-kinase (PI3K) and its downstream effector Akt (PI3K/Akt signaling pathway) [8]. This evidence concerns the gene AKT1 and acute coronary syndrome.